The Party Committee of the Company organized to preach the spirit of the 19th Congress.
Release time:
2020-08-14
11# August 29
Professor Shu Xiaoming is a member of the lecturer group of the Zhejiang Provincial Party Committee and has in-depth understanding and research on the history of the Communist Party of China and national policies. In the lecture, he summarized the main connotation of the spirit of the 19th National Congress of the Communist Party of China with "entering a new era, keeping in mind new missions, grasping new ideas, and promoting new development"; combined with the development achievements of the Communist Party of China since its establishment, it vividly explained China The cause of characteristic socialism emphasizes the importance of firm road self-confidence, theoretical self-confidence, institutional self-confidence, and cultural self-confidence; combined with the development of Marxism in China in China, the thought of socialism with Chinese characteristics in the new era is the inheritance and development of Marxism-Leninism, Mao Zedong thought, Deng Xiaoping Theory, the important thought of "three represents" and the scientific concept of development, the latest achievement of the Sinicization of Marxism, the crystallization of the practical experience and collective wisdom of the party and the people, and an important part of the theoretical system of socialism with Chinese characteristics, it is the action guide for the whole party and the people of the whole country to strive for the great rejuvenation of the Chinese nation. Professor Shu Xiaoming focused on the basic strategy of adhering to and developing socialism with Chinese characteristics in the new era, and carrying out national construction in two stages from 2020 to the middle of this century. He proposed that as a grassroots party member of an enterprise, it is necessary to earnestly understand the new development concept proposed by the 19th National Congress of the Communist Party of China, deeply understand the concepts of entering a new era, building a modern economic system, common prosperity, and shared development, and use them to guide work practice in order to fully grasp The pulse of the times, keep up with the pace of social development, so as to seize opportunities and achieve better development of enterprises.
Professor Shu Xiaoming's lecture was profound, vivid and funny, and was welcomed by Party members and cadres. Nearly 100 party members and cadres from the group headquarters and subordinate enterprises participated in the study. (Reporter
Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31